AYRWF
Ayr Wellness Inc.
$0.01
0.00 (-25.00%)
At close · Jul 8
Market Cap
$1.52M
Shares
108,759,747
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.01
Open$0.02
Day$0.01–0.02
52W$0.00–0.26
Avg vol 30d174K
Short int1K · 0.0% float · 1.0d
Short vol78%
DataDec 2020–Jul 2026
Equibles Rating
blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical
Strong Sell
Momentum
Very Weak
Sentiment
Bullish
Fundamentals
Weak
Quant / Vol
Very High
Market backdrop
VIX 16.9 · calm
Equity put/call 0.86
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−36%
below
Price vs 50-day avg
−21%
below
RSI (14)
43
neutral
MACD trend
Negative
52-week position
4%
near low
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−33%
trailing
6-month return
−52%
trailing
YTD return
−40%
this year
Relative strength
−59%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $0 › 200d $0 — 200d above 50d
Institutional flow
Accumulating
+33% holders QoQ · +1 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.00% of float · ▼ -45.6% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
4 holders — mid 4-yr range
Squeeze score
10
low risk · 0–100
Fundamentals
Revenue growth
+0%
Y/Y
Gross margin
38%
contracting
EPS growth
+12%
Y/Y
Free cash flow
$-8.1M
Balance sheet
$359.7M
net debt
Quant / Vol
risk profile
Volatility
499%
annualized · 1-yr
Max drawdown
−100%
past year
ATR
30.0%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
Technicals
trend & momentum for long-term holders Strong Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−36%
Bearish
Price vs 50-day avg
−21%
Bearish
RSI (14)
43
Neutral
MACD trend
Negative
Bearish
52-week position
4%
Bearish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $0 › 200d $0 — 200d above 50d
Institutional flow
Accumulating
+33% holders QoQ · +1 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.00% of float · ▼ -45.6% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
4 holders — mid 4-yr range
Price context
position in its 52-week range
52-wk low $0
Now $0 · 4%
52-wk high $0
vs 200-day avg -36%
vs 50-day avg -21%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Drug Manufacturers - Specialty & Generic — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
AYRWF
this stock
Ayr Wellness Inc.
|
$1.52M | -40.0% | +10.0% | — | 0.0% |
|
TAK
Takeda Pharmaceutical Co Ltd
|
$53.04B | +7.4% | — | — | 0.2% |
|
GALDY
Galderma Group AG/ADR
|
$50.73B | +4.9% | — | — | 0.0% |
|
JHPCY
Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR
|
$45.13B | — | — | — | 0.0% |
|
HLN
Haleon plc
|
$42.76B | -3.6% | — | — | 0.3% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Institutional Holders
Reducing
Holders
4
- % held
- 0.5%
- Net QoQ
- -658 sh
- Top holder
- First National Trust Co
Held
Float
Short & Settlement
Financials
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| AYRWF | -25.0% | -33.3% | -52.0% | -25.0% | -40.0% |
| SPY | -0.2% | +0.8% | +7.4% | -0.2% | +9.3% |
| vs SPY | -24.8% | -34.2% | -59.4% | -24.8% | -49.3% |